vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $39.6M, roughly 1.6× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 34.0%, a 1.9% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs -15.0%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CAC vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $39.6M |
| Net Profit | $21.9M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | — | 32.5% |
| Net Margin | 34.0% | 35.9% |
| Revenue YoY | — | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $1.29 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $39.6M | ||
| Q3 25 | $65.4M | $43.4M | ||
| Q2 25 | $62.3M | $43.4M | ||
| Q1 25 | $60.1M | $47.3M | ||
| Q4 24 | $47.6M | $44.4M | ||
| Q3 24 | $45.0M | $53.1M | ||
| Q2 24 | $42.8M | $53.1M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $14.2M | ||
| Q3 25 | $21.2M | $12.8M | ||
| Q2 25 | $14.1M | $2.5M | ||
| Q1 25 | $7.3M | $21.5M | ||
| Q4 24 | $14.7M | $6.5M | ||
| Q3 24 | $13.1M | $2.8M | ||
| Q2 24 | $12.0M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 32.5% | ||
| Q3 25 | 40.5% | 36.6% | ||
| Q2 25 | 28.5% | 33.6% | ||
| Q1 25 | 10.3% | 51.1% | ||
| Q4 24 | 38.7% | 10.6% | ||
| Q3 24 | 35.2% | 26.1% | ||
| Q2 24 | 34.7% | 51.4% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | 35.9% | ||
| Q3 25 | 32.4% | 29.6% | ||
| Q2 25 | 22.6% | 5.7% | ||
| Q1 25 | 12.2% | 45.4% | ||
| Q4 24 | 30.8% | 14.7% | ||
| Q3 24 | 29.1% | 5.3% | ||
| Q2 24 | 28.0% | 34.8% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.15 | ||
| Q3 25 | $1.25 | $0.12 | ||
| Q2 25 | $0.83 | $0.02 | ||
| Q1 25 | $0.43 | $0.21 | ||
| Q4 24 | $1.00 | $0.05 | ||
| Q3 24 | $0.90 | $0.03 | ||
| Q2 24 | $0.81 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | $514.4M | $42.8M |
| Stockholders' EquityBook value | $710.0M | $248.3M |
| Total Assets | $7.0B | $380.4M |
| Debt / EquityLower = less leverage | 0.72× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | — | $125.0M | ||
| Q3 24 | — | $137.4M | ||
| Q2 24 | — | — |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $248.3M | ||
| Q3 25 | $676.4M | $248.0M | ||
| Q2 25 | $652.1M | $244.6M | ||
| Q1 25 | $640.1M | $226.4M | ||
| Q4 24 | $531.2M | $195.1M | ||
| Q3 24 | $529.9M | $205.0M | ||
| Q2 24 | $508.3M | $8.8M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $380.4M | ||
| Q3 25 | $7.0B | $321.4M | ||
| Q2 25 | $6.9B | $315.3M | ||
| Q1 25 | $7.0B | $284.6M | ||
| Q4 24 | $5.8B | $266.1M | ||
| Q3 24 | $5.7B | $296.5M | ||
| Q2 24 | $5.7B | $19.5M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $52.0M | ||
| Q3 25 | $36.1M | $-20.9M | ||
| Q2 25 | $6.0M | $-8.3M | ||
| Q1 25 | $1.0M | $1.9M | ||
| Q4 24 | $60.9M | $-7.3M | ||
| Q3 24 | $-14.5M | $5.0M | ||
| Q2 24 | $14.5M | $19.2M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $51.2M | ||
| Q3 25 | $35.4M | $-20.9M | ||
| Q2 25 | $4.5M | $-8.6M | ||
| Q1 25 | $-727.0K | $1.7M | ||
| Q4 24 | $55.4M | $-7.9M | ||
| Q3 24 | $-16.2M | $4.6M | ||
| Q2 24 | $13.2M | $18.3M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 129.3% | ||
| Q3 25 | 54.1% | -48.3% | ||
| Q2 25 | 7.3% | -19.9% | ||
| Q1 25 | -1.2% | 3.5% | ||
| Q4 24 | 116.4% | -17.8% | ||
| Q3 24 | -36.0% | 8.7% | ||
| Q2 24 | 30.8% | 34.5% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 2.0% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | 2.4% | 0.7% | ||
| Q1 25 | 2.9% | 0.5% | ||
| Q4 24 | 11.7% | 1.3% | ||
| Q3 24 | 3.8% | 0.8% | ||
| Q2 24 | 3.0% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | 3.66× | ||
| Q3 25 | 1.70× | -1.63× | ||
| Q2 25 | 0.43× | -3.39× | ||
| Q1 25 | 0.14× | 0.09× | ||
| Q4 24 | 4.15× | -1.12× | ||
| Q3 24 | -1.11× | 1.77× | ||
| Q2 24 | 1.21× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
